| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZNF540 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | SPINK13 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | LNPEP | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | ZMYM4 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | RAB39A | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | WBSCR22 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | RP11-111M22.2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.009 |
| mRNA | MMP15 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | POLR3K | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | NUDT19 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
